跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMGALITY galcanezumab 120mg/mL prefilled pen - TGA Drug Approval Details
Approvals
/
TGA
/
EMGALITY galcanezumab 120mg/mL prefilled pen
Approved
STANDARD
EMGALITY galcanezumab 120mg/mL prefilled pen
Eli Lilly Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
bd2cfc226601ca38
Company
Eli Lilly Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
bd2cfc226601ca38
Product Name
EMGALITY galcanezumab 120mg/mL prefilled pen
Artg Id
302146
Artg Name
EMGALITY galcanezumab 120mg/mL prefilled pen
Sponsor
Eli Lilly Australia Pty Ltd
Company Detail Path
/organization/eli-lilly-australia-pty-ltd
Artg Date
2019-05-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/bd4a39b1a0ac08eb436df93b940a2aec.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/31003a673c8ae0e47ae27fe5e8b498dc.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
bd2cfc226601ca38
Type
Standard
Back to TGA Approvals